Description
In type 2 diabetic with CV risk for effective control & favorable PPG
Combination:
Voglibose 0.2 mg /0.3mg + Glimepiride 2 mg + Metformin 500 mg Tablets
- Reduces the risk of cardiovascular events
- Prevents nocturnal hypoglycemia
- Lowers the daily glycemic excursions
- Improved PPG more favorably than LSM (Life Style Modification)
- Decreases carbohydrate absorption and decreases PPHG
- Mobilizes endogenous pool of insulinotropics
- Does not alter rate of gastric emptying
- Well tolerated useful in elderly patients and in those with hepatic impairment or mild to moderate renal function
Best choice for the DIABETIC People with heart failure
Reviews
There are no reviews yet.